Introduction
Inflammation is critically involved in myocardial healing, and there is growing evidence that this inflammatory reaction determines outcome after acute myocardial infarction (AMI). 1 -3 Monocytederived macrophages play an important role in this process. Besides their phagocytic capacity, they stimulate neighbouring myofibroblasts to increase collagen production, thereby promoting cardiac repair. 4 Several experimental studies have shown that exaggerated monocyte/macrophage occurrence or activity leads to impaired myocardial healing following infarction 3 -6 and that therapeutic interventions are capable of dampening this process. 5, 7 On the other hand, reduced monocyte activation or low numbers of monocytes are also associated with healing defects and aggravated thrombus formation after myocardial infarction in mice and men. 8, 9 Therefore, it would be highly desirable to visualize monocyte/macrophage infiltration after myocardial infarction in a quantitative manner in terms of risk stratification and therapy monitoring. Recently, fluorine magnetic resonance imaging ( 19 F MRI) has emerged as a non-invasive background-free MR approach to image infiltrating monocytes. This technique utilizes perfluorocarbon (PFC)-containing nanoparticles taken up by circulating monocytes once given intravenously, which accumulate at the site of inflammation and can be visualized as 19 F hot spots. 10 This basic principle has been reported by our group and others to permit the sensitive and reliable detection of inflammation in various rodent models of inflammation using high magnetic field strengths of 7.0-9.4 Tesla. 10 -18 In contrast to paramagnetic MR-contrast agents like gadolinium 19 or ultra-small super-paramagnetic iron oxide particles (USPIOs), 20 19 F signal intensity (SI) is directly proportional to the local amount of PFC. 10 Thus, the derived 19 F integral reflects the regional content of monocytes, which makes 19 F MRI a quantitative tool. 10 In addition, this technique is highly sensitive and specific due to the lack of any fluorine background in the body as well as the preferential uptake of PFC nanoparticles into monocytes. 21 Furthermore, the physiological inertness of
PFCs makes them potentially applicable in humans. 11, 22 When translating 19 F MRI from the mouse model to large animals and from high-field MRI (9.4 Tesla) to typical clinical field strengths (3.0 Tesla), some critical issues need to be considered: the inflammatory response and thus the affinity of monocytes/macrophages to incorporate PFCs may substantially differ in mice and larger mammalians or even humans. 23 Compared with previous experiments in mice, the applied volume of PFC nanoemulsion per kilogram body weight (BW) needs to be reduced to avoid volume stress upon intravenous application. 10 Furthermore, perfluoro-15-crown-5 ether (PFCE), which exhibits ideal MRI properties due to its 20 chemical equivalent 19 F atoms and has been applied in prior murine modelsand for reference purposes in a subset of animals in the present study-accumulates and persists in the liver and spleen for months, rendering this particular PFC unsuitable for prospective human application. 17, 24, 25 However, alternative PFCs like perfluorooctyl bromide (PFOB) , which are eliminated within days, are available. They have already been tested in large doses in clinical trials as a blood substitute during surgery and exhibit a favourable safety profile. 22 One major limitation of PFOB is its decreased MRI sensitivity, which is caused by its complex MR spectrum. 26 Thus, dedicated imaging sequences are required to avoid artefacts in imaging PFOB nanoemulsions. 26 The aim of the present study in pigs was to investigate the feasibility of 19 F MRI for imaging monocytes in a clinical scanner at 3 T using PFOB as potential clinically applicable PFC. To this end, we induced myocardial infarction in pigs, known to result in a significant focal accumulation of monocytes, and administered PFOB as well as PFCE for reference purposes 10 and imagined the explanted hearts ex vivo 3 days thereafter.
Materials and Methods

Animal model and study protocol
Animal experiments were performed in accordance with the national guidelines on animal care and were approved by the state authority 'Landesamt für Natur-, Umwelt-und Verbraucherschutz (LANUV)'. The 12 laboratory mini pigs (Munich mini pigs, Troll, 55 -80 kg BW) used in this study were bred at the central animal facility of Heinrich Heine University, Düsseldorf, Germany. They were kept in individual boxes, fed with a standard chow diet, and received tap water ad libitum. The experimental protocol and study drop outs are outlined in Supplementary data online, Figure S1 . In brief, pigs were anaesthetized, intubated, and ventilated. AMI was induced by balloon angioplasty of the distal left anterior descending artery (LAD) under continuous recording of ECG and invasive blood pressure. One day after recovery, PFC nanoemulsions, either PFCE or PFOB, were administered intravenously at a dosage of 5 mL/kg BW, which were generated as described previously. 24 Thereafter, the animals were allowed to recover for additional 3 days. Venous blood was collected for analysis of infarct biomarkers and circulating inflammatory cells at baseline, Days 1 and 4 after myocardial infarction (see Supplementary data online, Table S1 ). Four days after myocardial infarction and 3 days after PFC application, gadolinium DTPA (Gadovist, 0.1 mmol/kg BW, Bayer Healthcare) was applied 15 min prior to euthanasia [pentobarbital (50 mg/kg BW) and 20 mL KCl] for subsequent detection of AMI via late gadolinium enhancement (LGE) ex vivo. Hearts were explanted and immediately perfused via the aorta with ice-cold phosphate-buffered saline, followed by 4% paraformaldehyde (PFA) and stored in PFA. MR measurements were carried out at room temperature.
In vitro uptake of PFC nanoemulsions into monocytes
Heparinized mouse, porcine, and human blood was incubated with FITC-labelled PFC nanoemulsion at a dilution of 1 : 20 at 378C using shaking culture bottles. For correction of unspecific particle adhesion, control experiments were performed on ice or with cytochalasin D (Sigma-Aldrich). At defined time points (2, 8, 32, 64 , 128 min after incubation), 200 mL of whole blood was taken, placed on ice, and lysed. Leucocytes were re-suspended in MACS buffer, pre-incubated with FcR blocking reagent (Miltenyi Biotech), and stained with antibodies against mouse, porcine, and human epitopes as shown in Supplementary data online, Table S2 . This assay was validated by a commercially available phagocytosis kit based on FITC-labelled latex beads (Fluoresbrite, Polyscience). For the analysis of leucocyte composition and particle uptake into monocytes, flow cytometry was performed with a FACS CANTO II (Becton Dickinson) equipped with three lasers and capable of detecting up to eight colours. Data were analysed with FACS Diva (Becton Dickinson) and presented with KALUZA (Beckman Coulter).
Magnetic resonance imaging
Measurements were performed on a whole-body 3.0 T Achieva MR scanner (Philips Healthcare, Best, the Netherlands) at the German Diabetes Center (Düsseldorf, Germany 
Offline data analysis
Proton and fluorine images were stored in DICOM format and imported into the 3D visualization software Amira 4.0 (Mercury Systems, USA) for quantitative analysis, segmentation, and fusion of 
Statistical analysis
Unless otherwise stated, data are presented as mean values + SD. Data were analysed by the Mann-Whitney U test or Student's t-test as appropriate. The level of statistical significance was set to 5% (P , 0.05). Linear regression analysis was done with Sigma Stat 4.0 (Systat Software, Inc.).
Results
Myocardial infarction in pigs and analysis by 19 
F MRI
Twelve pigs entered the study protocol as outlined in Supplementary data online, Figure S1 , and underwent balloon angioplasty to provoke AMI as schematically indicated in Figure 1A . Three pigs died due to therapy-resistant ventricular fibrillation (25% mortality), while two of the surviving pigs were excluded from the study since they did not show any sign of myocardial infarction (Supplementary data online, Figure S1 ).
Since all previous studies with 19 F MRI in rodents were conducted with PFCE, we first tested this PFC as proof of concept and as a reference agent compared with previous mice experiments in two pigs. As shown in representative Figure 1B , the explanted heart (4 days after reperfused AMI) exhibited typical macroscopic tissue alterations in the area downstream of the occluded coronary vessel (red dotted line, Figure 1A) . The respective 19 F MRI is given in Figure 1C . The mean 19 F signal-to-noise ratio (SNR) was 20.4 (n ¼ 2), the imaging duration ,20 min, and the image resolution 2 × 2 × 8 mm In separate phantom experiments (Supplementary data online, Figure S2 ), we observed a comparable SNR for PFCE and PFOB at 3 T. Due to the excellent SNR of PFOB, we used this PFC for the remaining five animals of the study. The mean 19 F SNR for PFOB at identical spatial resolution and imaging duration was 15.6 + 3.3 (n ¼ 5).
Histological validation of 19 F signals after myocardial infarction and comparison with LGE
Next, we compared short-axis slices within the infarcted area containing (Figure 2A) , matches the area of myocardial damage indicated by MTS histology, as was anticipated ( Figure 2B ). In contrast, the 19 F signal ( Figure 2C) more closely matches the area depicted by the histological macrophage stain (red line, Figure 2D ). Figure 2E ) is not homogenously distributed across the area of the infarcted myocardium as delineated by LGE. Within AMI, the antero-septal myocardium is characterized by a transmural 19 F signal while anterolateral area exhibits the 19 F signal only in the epicardial layer, leaving parts of the infarcted heart without the 19 F signal (star, Figure 2E ). The overlay of both histological borders of myocardial damage (grey) and macrophage presence (red) clearly shows an area of AMI devoid of macrophage infiltration (star, Figure 2F ). F signals, measurements of selected tissue sections from short-axis slices were carried out at 9.4 T. Figure 3A displays a short-axis image of an infarcted heart with LGEpositive myocardium. The septum, parts of the right ventricle (RV) and the anterior wall were identified by LGE as infarcted myocardium. Figure 3B shows the area positive for LGE merged with the high-resolution information of 19 F MRI imaged at 9.4 T. The 19 F signal again was distributed across the area of myocardial infarction in a 'patchy' fashion: the 19 F signal was mainly present in the anterior myocardial wall and the anterior insertion of the RV, while the left myocardial septum was LGE positive LGE (black, grey) and 19 F (red) datasets with incongruent areas leaving a part of LGE without 19 
F signal (star). (F) Schematic histological merged imaging of MTS (black line, purple) and MHCII
+ stain (red line, blue) leaving a part of MTS without MHCII stain (star).
Imaging infarct inflammation with 19 F MRI at 3 T but did not exhibit any 19 F signal. Tissue staining for macrophages (MHCII) revealed that the left myocardial septum was not infiltrated by macrophages (1), while the anterior insertion of the RV (2) and especially the infarcted anterior wall of the left ventricular myocardium (3) were densely infiltrated by monocytes ( Figure 3C ). Strong infiltration of monocytes was seen in the vicinity of a vessel (4). The 19 F SI and macrophage frequency correlated with R 2 ¼ 0.94 (P , 0.05; Figure 3D ).
Global and regional analysis of myocardial
LGE and 19 Figure 4A . The total volume of 19 F-positive myocardium (in mL) correlated well (R 2 ¼ 0.97, P , 0.01) with total volume positive for LGE (in mL) in the five hearts analysed ( Figure 4B ). In these hearts, global 19 F volume was always smaller than the LGE volume (75.7+19.6% of LGE-positive volume). We therefore assessed the distribution of LGE-and 19 F-positive myocardium in a slice-by-slice manner in the five hearts from animals treated with PFOB. To this end, infarcted myocardium (LGE positive) was subdivided into four short-axis slices from base to apex as indicated in Figure 4A (dotted and numbered lines) , and the local ratio of LGEto In vitro uptake of PFC nanoparticles into human and porcine leukocytes
With regard to the high SNR of 19 F MRI in our model, we wondered whether this might be related to species-dependent differences in the phagocytic capacity of monocytes. Consistent with data in the literature, 27, 28 we found that the fraction of monocytes within the total leukocyte population is higher in pigs when compared with mice (pigs: 6.6+2.4%, mice: 4.2+1.3%, Figure 5A ). More importantly, porcine monocytes exhibited a substantially higher nanoparticle uptake compared with murine monocytes [mean fluorescence intensity (MFI): 4035 + 1435 vs. 1524 + 1281, P , 0.05]. In view of the translational nature of our study, we also investigated the phagocytic properties of human monocytes. Uptake of PFCs by human monocytes-human blood exhibited the highest fraction of monocytes (8.3+2.8%) among the three species analysed-exceeded that of pigs about 1.5-fold (6610+3800, P , 0.01, Figure 5B ).
Discussion
This study provides first evidence that 19 F MRI of inflammatory processes resulting from AMI is feasible in the explanted heart at 3.0 T field strength using a pre-clinical, large animal infarct model. We Imaging infarct inflammation with 19 F MRI at 3 T found an apico-basal 19 F gradient within the infarcted pig myocardium in which the 19 F signal matched the monocyte/macrophage appearance. When compared with homogeneous LGE, the 19 F signal showed an inhomogeneous pattern with predominance in basal and epicardial myocardial regions, suggesting that inflammatory processes do not evenly affect all areas of the ischaemic tissue. The patchy pattern resembles the human inflammatory pattern observed in histological examination of non-survivors of AMI. 2 Given the sensitivity of 19 F detection and use of non-toxic PFOB nanoemulsions, repetitive 19 F MRI in a clinical scanner may be possible to monitor the inflammatory response following myocardial infarction. 19 F MRI has emerged as a valuable method for in vivo cell tracking using PFC-containing nanoemulsions. 11, 21, 29 It has been demonstrated in various experimental disease models that circulating monocytes are the main immune cell species which becomes labelled after intravenous injection with PFCs. 10,13 -15,21 Fluorine-labelled monocytes migrate to the site of inflammation and can subsequently be visualized as hot spots in a quantitative manner. 10 The findings of the present pilot study indicate that quantitative monocyte tracking with 19 F MRI is also feasible in larger mammals.
The LGE technique, based on the distribution of a contrast agent in necrotic or fibrotic tissue, 30 has proved to be a valuable tool to estimate functional recovery after myocardial infarction. 31 However, the outcome of an ischaemic insult is not only influenced by the mere size of an infarct but is also critically influenced by the inflammatory response. 1, 3 Our study demonstrates that recruitment of 19 F-labelled monocytes into the injured myocardium at Day 4 after infarction follows a pattern, which is not congruent with the gadoliniumpositive myocardium. Similar observations were recently made in rodent myocardial infarction models at 7 and 9.4 T using PFCE. 12, 17 The discrepancy between gadolinium-positive injured tissue and the distribution of the 19 F label is suggestive of microvascular obstruction. Since this phenomenon is frequent in reperfused AMI in humans, 32 the combined measurement of LGE and monocyte infiltration with 19 F MRI might provide a relevant index of microvascular obstruction. One should keep in mind, however, that 19 F imaging at Day 4 represents only a snapshot of the healing process after infarction, which starts from the border zones and advances towards the inner infarct layers in a 'wave-front' pattern. 2 Thus, in future studies, the sequential acquisition of 19 F signals at later stages of the healing process may provide a more complete coverage of the whole in vivo inflammatory process.
At present, USPIOs similar to PFCs permit in vivo inflammation imaging. USPIOs have recently been used for inflammation imaging after myocardial infarction in humans. 20, 33 While MR detection of inflammation with USPIOs relies on signal depletion, which may be difficult to interpret in some cases, imaging based on the positive PFC signal is highly sensitive and specific due to the lack of any background. When compared with PFCs, inflammation imaging with USPIOs cannot differentiate between USPIO-containing monocytes/macrophages and the iron content of tissue, e.g. secondary to haemorrhage, which frequently occurs following reperfusion of the infarcted myocardium. 32 Moreover, only 19 F MRI can be used simultaneously with LGE ( 1 H MRI) for combined imaging of local inflammation and tissue damage.
When translating monocyte imaging with 19 F to a human MR scanner, the sensitivity of detection is of major importance. Surprisingly, in the context of previous mouse experiments, injection of about one-fourth of the PFCE emulsion-when related to BWyielded an adequate SNR at acquisition times of ,20 min despite the decrease in magnetic field strength. This unexpected sensitivity may relate to the fact that the monocyte concentration in pigs is about double of that found in mice. In addition, the ability of pig monocytes to phagocytize PFC nanoparticles was found to be approximately doubled compared with mice ( Figure 5) . A further sensitivity factor to be considered is the voxel size, which increased from 0.5 × 0.5 × 2 mm 3 at 9.4 T to 3 × 3 × 3 mm 3 at 3.0 T, thereby partially compensating for the loss in magnetic field strength. 34 To achieve an SNR similar to that of PFCE, we increased the fluorine content of the nanoemulsion in the PFOB experiments to 50% (w/w). The fluorine content could potentially be increased further, since stable PFOB emulsions with up to 100% w/v (65% w/w) have been applied clinically to improve oxygen delivery. 35 Clinical translation of the 19 F imaging concept requires PFCs that exhibit a short biological half-life. PFCs are generally considered to be metabolically inert and are primarily released from the organism by exhalation via the lung, which is determined by the physicochemical properties of PFCs. 36 Despite excellent imaging properties, PFCE has a biological half-life exceeding 100 days, 35 thus precluding a future clinical application. On the other hand, the half-life of PFOB, primarily eliminated by exhalation, has been reported to range between 3 and 8 days. 24 This advantageous feature is further highlighted by the fact that PFOB has already been used as a blood substitute (oxygen carrier) during surgery in clinical studies. 22 Despite its advantageous biological features, the MR properties of PFOB still pose a challenge due to its complex spectrum. While the present study used a 3D UTE sequence for artefact-free imaging, 26 improvements in dedicated acceleration techniques such as parallel imaging in combination with compressed sensing are expected to further increase the sensitivity of 19 F MRI.
The present study was planned as pilot study, showing that 19 F MRI-based monocyte tracking after AMI is achievable in a large animal model. However, prior to a future broader application of 19 F MRI, this will require true in vivo measurements of the inflammatory state post-MI in a clinical scanner. This includes measurement of the pharmacokinetics of PFCs in blood together with the temporal accumulation of the 19 F signal over the injured heart. With this information, the optimal time point of data acquisition can be determined, which will also be relevant for the repetitive assessment of inflammation.
In summary, the present study demonstrates that imaging of inflammation associated with cardiac ischaemia and reperfusion is feasible in the explanted pig heart using PFOB and 19 F MRI at 3 T. Since the signal from LGE does not concur with the distribution of the 19 F signal from monocytes, the combined measurement of LGE and 19 F might permit novel insights into the in vivo pathophysiology of myocardial infarction.
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